Investing in Innovation: Femtech and Women’s Health Funding With Rachel Bartholomew

Investing in Innovation: Femtech and Women’s Health Funding With Rachel Bartholomew

In this episode of "me-search," JT speaks with Rachel Bartholomew founder of Hyivy, Femtech Canada, and Femtech Across Borders. While recovering from a hysterectomy and lymphadenectomy, Rachel recognized the need for innovation in pelvic health. This led her to reinvent the 80-year-old dilator and create a holistic device designed to treat, monitor, track, and prevent various pelvic symptoms. This is how Hyivy was born.  JT and Rachel discuss the importance of femtech, women’s health funding, and the evolving and sometimes frustrating landscape of women’s health initiatives. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Why does HRT have a bad rap? Recent findings explained by Jenna Dunlop, PhD in Evolutionary Biology

On the first episode of "me-search" JT sits down with resident Herstasis 'Knowledge Translation' specialist, Jenna Dunlop, PhD, who talks recent findings on Hormone Replacement Therapy (HRT). She delves into its evolution, dispels misconceptions surrounding its controversial reputation, and underscores the pressing need to prioritize women's menopause health in the medical system. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.